Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
65.79
+2.15 (3.38%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
65.63
-0.16 (-0.24%)
Bozordan keyin: Jun 26, 2026, 6:58 PM EDT
Bright Minds Biosciences Inc., biotexnologiya kompaniyasi, Amerika Qo'shma Shtatlarida og'ir va hayotni o'zgartiruvchi kasalliklarga chalingan bemorlarning hayotini yaxshilash uchun terapevtik vositalarni ishlab chiqadi. Uning portfeliga 5-HT2 Retseptorlari, epilepsiya va neyropsixiatrik kasalliklar uchun serotonin agonistlari kiradi; va BMB-101, bu noma'lum tirishish buzilishi uchun 1-bosqich sinovlarini yakunlagan va rivojlanish va epileptik ensefalopatiyalar va absans epilepsiyalari uchun 2-bosqich klinik sinovlarida. Kompaniya, shuningdek, neyropsixiatrik va nevrologik ko'rsatkichlarni davolash uchun BMB-201 va BMB-202; va Prader Willi sindromini davolash uchun 5-HT2C agonisti bo'lgan BMB-105ni ishlab chiqadi. Bright Minds Biosciences Inc. kompaniyasining BREAKTHROUGH tadqiqotidagi elektroensefalogramma (EEG) ma'lumotlarini tahlil qilish uchun Firefly Neuroscience, Inc. bilan hamkorlik qiladi. Kompaniya 2017 yilda tashkil etilgan va Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Emer Leahy M.B.A., Ph.D. | Consultant |
| Dr. Jan Torleif Pedersen M.Sc., Ph.D. | Chief Science Officer & Director |
| Dr. Stephen D. Collins M.D., Ph.D. | Chief Medical Officer |
| Mr. Alex Vasilkevich | COO & Senior Scientific Officer |
| Mr. Ian McDonald | Co-Founder, CEO, President & Director |
| Mr. Ryan E. S. K. Cheung B.Com., C.A., CPA | CFO & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-03 | 6-K | form6k.htm |
| 2026-06-02 | 6-K | form6k.htm |
| 2026-05-28 | 6-K | f6k-20260526.htm |
| 2026-05-20 | 6-K | form6k.htm |
| 2026-02-13 | 6-K | form6k.htm |
| 2026-01-09 | 6-K | form6k.htm |
| 2026-01-08 | 6-K | f6k20260107.htm |
| 2026-01-07 | 6-K | f6k20260106launch.htm |
| 2026-01-06 | 6-K | f6k20260106nr.htm |
| 2026-01-05 | 6-K | f6k-20260105.htm |